跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TUDORZA GENUAIR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TUDORZA GENUAIR
Authorized
STANDARD
TUDORZA GENUAIR
Covis Pharma GmbH
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e71d3ea0f3e76ca3
Company
Covis Pharma GmbH
Type
Standard
Approval Details
Approval Id
e71d3ea0f3e76ca3
Drug Approval Canada Name
TUDORZA GENUAIR
Product Name
TUDORZA GENUAIR
Status
Marketed
Status Date
2022-09-12
Original Market Date
2013-09-13
Din
02409720
Drug Class
Human
Dosage Form
Powder (Metered Dose)
Route Of Administration
Inhalation
Schedule
Prescription
Ahfs
12:08.08
Atc Original
R03BB05 ACLIDINIUM BROMIDE
Atc Name
r 03 bb 05
Aig Number
0154531001
Company Name
Covis Pharma GmbH
Company Address
Grafenauweg 12, Zug, Zug, Switzerland, 6300
Company Detail Path
/organization/covis-pharma-gmbh
Company Information
Pharmaceutical Company Name
Covis Pharma GmbH
Country Name
Switzerland
Province Name
Zug
City Name
zug,zug,country_ch
Address
Grafenauweg 12
Active Ingredients
ACLIDINIUM BROMIDE
400 MCG / ACT
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e71d3ea0f3e76ca3
Type
Standard
Back to Health Canada Approvals